Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`Title of Invention:
`
`METHODS AND SYSTEMS FOR IDENTIFYING BRAIN DISORDERS
`
`
`
`——
`
`——
`
`Payment information:
`
`Submitted with Payment
`
`no
`
`File Listing:
`
`Document
`Number
`
`Document Descri
`
`tion
`
`p
`
`File Size(Bytes)/
`Message Digest
`31 0450
`
`Pages
`Multi
`Part /.zip (if appl.)
`
`0e54
`
`l
`
`53242-701-3OI_IDS.pdf
`
`ce7d7d3ed8f3344e284120999130846361
`
`
`
`Multipart Description/PDF files in .zip description
`
`Transmittal Letter
`
`Information Disclosure Statement (IDS) Form (SBO8)
`
`Information:
`
`Non Patent Literature
`
`2016ALZHE|MERDISEASEFACTS
`.PDF
`
`f095761 l b67d32f6fe268fc75 l47dal4a783
`af7f
`
`893242
`
`Non Patent Literature
`
`AUGUSTINACK_ENTORHINALV
`ERRUCASEGEOMETRY_85—96.
`P D F
`
`935347aoc742b415163772749a9ebbe2fa ‘
`20c7
`
`683983
`
`The page size in the PDF is too large. The pages should be 8.5 x11 or A4. If this PDF is submitted, the pages will be resized upon entry into the
`Image File Wrapper and may affect subsequent processing
`
`
`
`Information:
`
`Information:
`
`Information:
`
`Information:
`
`N0” Patent L'terature
`
`BAKKER_LYMPHATICCLEARAN
`CEOFTHEBRA|N_181—194.PDF e963ffa43ef6f7d521 d714cbd45560921f6f7
`bfc
`
`9285260
`
`N0” Patent L'terature
`
`BARNElT_EARLY|NTERVENTIO
`NINALZHEIMERS_101.PDF
`
`42flfel4006aldd51616ebc3ec8e8d83223 A
`5d75
`
`462549
`
`Non Patent Literature
`
`CASH_THEPAlTEROFATROPHY
`_1425—1433.PDF
`
`ce902f0335Cf67acd7af4f03e8356c02455e1
`2f6
`
`808475
`
`
`
`Non Patent Literature
`
`CAVEDO_THEROADADHEADTO
`CURE_181—202.PDF
`
`c102db0308541ec78031a40f2c308d0f1e4 -
`f142
`
`18327985
`
`Non Patent Literature
`
`CHEN_DETECT|NGMICROSTRU
`CTURALPROPERTIES_1—9.PDF 87c49c7e0e1 f1 b233d3ad57ac7463595ff5f3
`033
`
`1600698
`
`Non Patent Literature
`
`FISCHER_CONVERSIONFROMS
`UBTYPES_288—291.PDF
`
`4edb439bf9ba1dc94f8743dd4f6838b033b
`4e598
`
`360324
`
`359a
`
`Non Patent Literature
`
`FRIEDMAN_USPREVALENCEAN
`DPREDICTORS_1637—1641.PDF 16feec3c723fda4bcc483932b69fee3956d8
`6daa
`
`4851899
`
`Non Patent Literature
`
`GAUTHIER_M|LDCOG NTITIVEIM
`PARIMENT_1262—1270.PDF
`
`120974b90baadf3b747e8540d8ebaca§27d
`7e229
`
`387797
`
`Non Patent Literature
`
`GREENE_SUBREGIONSOFTHE|N
`FERIOR_1304—1311.PDF
`
`341171648ff42684b1271a9b14cc8c284b61
`0df1
`
`429402
`
`Non Patent Literature
`
`HAMPEL_CORECAND|DATENEU
`ROCHEMICAL_38—48.PDF
`
`3bf58ef4833d3f1443bfe04efb6258cdc2b9
`
`435176
`
`
`
`Non Patent Literature
`
`HEBERT_ANNUAL|NC|DENCEO
`ALZHEIMER_16—173.PDF
`
`cd1d8484eab2218f822c46c7356ad271b18
`0733f
`
`207190
`
`Non Patent Literature
`
`HERBERT_ALZHE|MERD|SEASE|
`NTHEUS_1778—1783.PDF
`
`898fce0b5432bf3067843de8¢1f9bc1403
`157b
`
`4571705
`
`Non Patent Literature
`
`HRABETOVA_DEADSPACEMICR
`ODOMAINS_8351—8359.PDF
`
`423d9e0e7e981b20c597b0f9cb7dad27ed1
`6c536
`
`705081
`
`.-
`
`Non Patent Literature
`
`8915308
`
`HUANG_LONGITUD|NALMEAS
`UREMENTANDHEIRARCHIACAL
`3 9880_ P D F
`_
`
`74b2dba9eofe9asoocf1b2960b4fi134529e
`d954
`
`Non Patent Literature
`
`JEN KINS_DEVELOPMENTALAN
`DAG E—
`RELATEDCHANGES_1634—1640. ad4eb5175E457709fd22479ad0342223ba4
`PDF
`f415f
`
`610262
`
`Non Patent Literature
`
`ZARE_BRA|NEXTRACELLU LAR_
`282—286.PDF
`
`4af9f4d2e9c20bc30f6c5123f4d58bd73829
`d344
`
`KAMALI—
`
`1354805
`
`Non Patent Literature
`
`KLOPPEL_D|AGNOSTICNEURO|
`MAGING_457—463.PDF
`
`6dcf3f5f5b749070615f5118b886966adbad
`bch
`
`1274587
`
`
`
`Non Patent Literature
`
`KRUGGEL_ANALYS|SOFLONGIT
`UDINALDIFFUSION_101—115.
`P DF
`
`Ucbegaosbisi 07f78decae7593c469725c0
`8b38e
`
`700523
`
`Non Patent Literature
`
`LERCH_STYD|NGNEUROANATO
`MYUSEINGMRI_314—326.PDF
`
`2ef29bd7d7d6d630f8c1129481dd22f5470
`09632
`
`15441847
`
`Non Patent Literature
`
`L|EBMANN_THREED|MENSION ‘
`LSTUDY_1138—1152.PDF
`
`985c96d9937f04b5cd4be69f289506548f1 '
`633b
`
`2356208
`
`Non Patent Literature
`
`MAYO_LONGITUD|NALCHANG
`ESINMICROSTRUCTURAL_330—3
`38_ P DF
`
`d73f76ef28c1b2f7351ce7407cbffad46273d
`3w
`
`9994358
`
`95f9f
`
`Non Patent Literature
`
`NICHOLSON_BRA|NEXTRACELL
`ULARSPACE_309—325.PDF
`
`7fae46417f4f96e74c5e38db11588c450e99
`8431
`
`1193255
`
`Non Patent Literature
`
`NICHOLSON_DIFFUSIONOFMO
`LECULESINBRA|N_129—154.PDF 7c24ce1b8e798552083154f65d3fc5956ce2
`Cfo
`
`1950704
`
`Non Patent Literature
`
`NICHOLSON_EXTRACELLULARS
`PACESTRUCTURE_207—215.PDF dc95fae573e262f22915d9e33734db4a435
`
`667852
`
`
`
`Non Patent Literature
`
`NICHOLSON_H|NDEREDD|FFUS
`IONOF_2277—2290.PDF
`
`020cbb2308e90e1f42b4e784986047d8e72
`961f2
`
`7860145
`
`Non Patent Literature
`
`PAUS_INFERRINGCAUSALITYIN
`BRA|N_1109—1114.PDF
`
`4b57f028544fd3b5c3271f862912fd35f6e9 I
`
`1056076
`
`Non Patent Literature
`
`PCTUSZO17064745_ISRWO_21 '
`EBZO18.PDF
`
`817989
`
`592947330f46399fc4fdfaabde53b908ef81
`18e
`
`576759
`
`70707
`
`Non Patent Literature
`
`PETERSEN_M|LDCOGNTIVIEIMP
`AIRMENT_303—308.PDF
`
`1c18d30f94d9c29dfaae3cca437d4027f52e
`bea
`
`Non Patent Literature
`
`RUAN_POTENTIALNEURO|MAG
`INGBIOMARKERS_104.PDF
`
`6263c6715633ef33763ae007ac6182f11efd
`d28d
`
`13160364
`
`Non Patent Literature
`
`SYKOVA_CHANGES| N EXTRACE
`LLULARSPACE_479—484.PDF
`
`31014713978377deZaf925966907372998
`361C6
`
`4454339
`
`Non Patent Literature
`
`SYKOVA_D|FFUSION|NBRA|N_1
`277—1340.PDF
`
`f2933d5063750d7c6d908dc00dbachBdZ -
`
`2406893
`
`
`
`Non Patent Literature
`
`TAO_MAX|UMUGEOMETRICAL
`H|NDRANCE_59—68.PDF
`
`e86cdbd27de521b31be43b314fb4d63e0d‘
`e2f6a
`
`1186394
`
`Non Patent Literature
`
`THOMANN_THECEREBELLUM|N
`MILDCOGNTIV|E_1 198—1202.
`P DF
`
`f783445b1abbf4db3432d007bd72cf03142
`wws
`
`221731
`
`Non Patent Literature
`
`VISHNU_|MPL|CAT|ONSOFPRES
`YM PTOMATIC_E258.PDF
`
`7cd3711f383df249b7e3cfc21bcdee97959d
`333f
`
`417737
`
`Non Patent Literature
`
`WEIMER_EARLY|DENTIFICATIO
`NAN DTREATMENT_21 5—226.
`PDF
`
`4531316dd658e538dbb51fab9b523113b95
`337503
`
`521018
`
`fBbd
`
`Non Patent Literature
`
`WIENER_2014UPDATEOFTHEA
`ZHEIMERSDISEASE_E1—120.PDF 71428f93208665c73833328641441c1eec71
`41d6
`
`9730536
`
`Non Patent Literature
`
`XIE_SLEEPDRIVESMETABOLITEI
`LEARANCE_373—377.PDF
`
`d109f8529ff34bfc133b2cb579d38017d49d
`8c04
`
`6044090
`
`Non Patent Literature
`
`YOSHIYAMA_SYNAPSELOSSAN
`DMICROGLIAL_337—351.PDF
`
`8c03f6207d1d50cdf53b8c8e26ab868cf456
`
`6963522
`
`
`
`.
`Non Patent Literature
`
`YOUSEFNEZHAD_UN|F|EDMOD
`ELOFBRA|N_O32411.PDF
`
`6f41ad720810666727e7e69f775dc590fe69
`882b
`
`607282
`
`'
`Non Patent Literature
`
`SCHMAND METAANALYSISOF
`—
`CSF_135—145.pdf
`
`42478c40c6396d5b77334fd710399539de
`200ca
`
`430981
`
`16
`
`12
`
`Information:
`
`Information:
`
`Total Files Size (in bytes)
`
`145236781
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`
`
